Skip to content
2000
Volume 17, Issue 3
  • ISSN: 1574-8928
  • E-ISSN: 2212-3970

Abstract

Background: Transdermal drug delivery is an emerging and appealing alternative to oral and hypodermic drug delivery systems. With the new developments in skin penetration techniques, anticancer drugs ranging from hydrophilic macromolecules to lipophilic drugs can be administered via a transdermal route to treat cancer. Objective: In the present review, various approaches to enhance the transdermal delivery of drugs are discussed, including micro and nanotechnology-based transdermal formulations like chemotherapy, gene therapy, immunotherapy, phototherapy, vaccines, and medical devices. Limitations and advantages of various transdermal technologies are also elaborated. Methods: In this review, patent applications and recent literature of transdermal drug delivery systems employed to cure mainly cancer are covered. Results: Transdermal drug delivery systems have proved their potential to cure cancer. They increase the bioavailability of the drug by site-specific drug delivery and can reduce the side effects/- toxicity associated with anticancer drugs. Conclusion: The potential of transdermal drug delivery systems to carry the drug may unclutter novel ways for therapeutic intercessions in various tumors.

Loading

Article metrics loading...

/content/journals/pra/10.2174/1574892816666211202154000
2022-08-01
2025-10-08
Loading full text...

Full text loading...

/content/journals/pra/10.2174/1574892816666211202154000
Loading

  • Article Type:
    Review Article
Keyword(s): Cancer; drug delivery system; nanotechnology; patents; skin cancer; transdermal
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test